Reimbursed medicines
by gross spend
| Rank | Medicine | Therapeutic group | 2022 Spend |
|---|---|---|---|
| 1 | Adalimumab | Immunosuppressants | $113.59 |
| 2 | Dabigatran | Antithrombotic Agents | $48.55 |
| 3 | Pembrolizumab | Immunosuppressants | $46.27 |
| 4 | Budesonide with eformoterol | Respiratory | $41.87 |
| 5 | Trastuzumab | Immunosuppressants | $40.08 |
| 6 | Lenalidomide | Oncology | $38.75 |
| 7 | Insulin glargine | Diabetes | $36.89 |
| 8 | Rivaroxaban | Antithrombotic Agents | $34.22 |
| 9 | Glecaprevir and pibrentasvir | Antivirals | $32.42 |
| 10 | Palbociclib | Oncology | $29.31 |
| 11 | Abiraterone acetate | Oncology | $28.71 |
| 12 | Rurioctocog alfa pegol [Recombinant factor VIII] | Blood and Blood Forming Organs | $27.22 |
| 13 | Etanercept | Immunosuppressants | $28.71 |
| 14 | Pneumococcal (PCV10) vaccine | Vaccinations | $24.14 |
| 15 | Aflibercept | Immunosuppressants | $24.07 |
| 16 | Diphtheria, tetanus, pertussis, polio, hepatitis B and haemophilus influenzae type B vaccine | Vaccinations | $22.95 |
| 17 | Secukinumab | Immunosuppressants | $20.69 |
| 18 | Dolutegravir | Anti-infectives | $20.66 |
| 19 | Empaglifilozin | Diabetes | $20.04 |
| 20 | Human papillomavirus vaccine [HPV] | Vaccinations | $17.75 |
| Total | $693.00 |